跳至主要内容
临床试验/NCT05237830
NCT05237830已完成不适用

Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty: a Single-center Retrospective Study

University of Liege1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
Cell savage use

研究概览

简要总结

Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Eligible patients were adults undergoing elective aseptic revision of hip arthroplasty at the department of orthopedic surgery of the University Hospital of Liege between 01 January 2011 and 31 December 2020.

排除标准

  • Patients undergoing revision for infection or with local malignancies were excluded from this study.

结局指标

主要结局

Cell savage use

时间窗: during the surgical procedure

The primary outcome was the proportion of patients in whom the cell saver was effectively used (%)

次要结局

  • Aspirated blood(during the surgical procedure)
  • Re-infused(during the surgical procedure)
  • Hemoglobin(during the surgical procedure)
  • Allogenic Transfusion(7 days)
  • Fluid(during the surgical procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Carella

Principal Investigator

University of Liege

研究点 (1)

Loading locations...

相似试验